Fortrea (FTRE) Stock: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$20.00
0.60 (3.09%)
â˛
5d:
+0.55%
30d:
+8.93%
90d:
+12.04%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: FTRE is fairly priced but lacks strong directional signals. At 4.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: FTRE is fairly priced but lacks strong directional signals. At 4.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.12
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.19
5.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $20.00, which is considered fair relative to its 30-day fair value range of $17.73 to $19.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.7) compared to its historical average (15.5). At these levels, the market is pricing in 4.5% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $19.05, while resistance sits at $20.97. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: FTRE scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $19.05, while resistance sits at $20.97. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: FTRE scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$17.73 -
$19.98
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- NEUTRAL: Near Wall St target ($20.75)
- BULLISH: Expecting earnings turnaround to 4.5% growth with -4.5% revenue growth
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$17.73 -
$19.98
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$19.05
Resistance Level
$20.97
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.69
Wall Street Target
$20.75
(+3.8%)
Revenue Growth (YoY)
-4.5%
Earnings Growth (YoY)
-57.4%
Profit Margin
-3.2%
Valuation Premium vs History
+4.5% premium
PE vs Historical
17.7 vs 15.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.5%
(market-implied from PE analysis)
1-Year Target
$20.90
(+5%)
2-Year Target
$21.84
(+9%)
3-Year Target
$22.82
(+14%)
3-Yr Target (if PE normalizes)
(PE: 18â16)
PE COMPRESSION
$19.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 34.4%)
$55.94
(+180%)
Base:
(SPY PE: 17.7, Growth: 34.4%)
$48.51
(+143%)
Bear:
(PE: 15.0, Growth: 34.4%)
$41.24
(+106%)
Share & Embed Analysis
Last updated: October 03, 2026 1:04 PM ET
Data refreshes hourly during market hours. Next update: 2:04 PM
Data refreshes hourly during market hours. Next update: 2:04 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
